NEUROLEPTICS CAUSE STIMULATION OF DOPAMINE D-1 RECEPTORS AND THEIR DESENSITIZATION AFTER CHRONIC TREATMENT

被引:17
作者
IMPERATO, A
OBINU, MC
CARTA, G
MASCIA, MS
CASU, MA
DAZZI, L
GESSA, GL
机构
[1] 'G.M. Everett' Laboratory of Neuropsychopharmacology, 'Bernard B. Brodie' Department of Neuroscience, University of Cagliari, Cagliari
关键词
NEUROLEPTIC; DOPAMINE RELEASE; ACETYLCHOLINE RELEASE; DOPAMINE D-1 RECEPTOR STIMULATION; DOPAMINE D-1 RECEPTOR DESENSITIZATION; (THERAPEUTIC AND COLLATERAL EFFECT);
D O I
10.1016/0014-2999(94)90635-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Recent evidence indicates that the neuroleptic-induced increase of in vivo acetylcholine output in the striatum does not depend on the relief of cholinergic neurons from the inhibitory control by dopamine, but on increased dopamine output onto dopamine D-1 receptors. The present microdialysis study was aimed at finding if the neuroleptic-induced increase in striatal acetylcholine release persists after chronic treatment, and how it is correlated with dopamine output. Rats were chronically treated with the dopamine D-2 receptor antagonists, haloperidol and (-)-sulpiride (0.5 mg/kg and 50 mg/kg i.p., respectively, daily, for 30 days). The stimulant effect of both neuroleptics on striatal dopamine release persisted unaltered throughout the chronic treatment (by about 100% over basal values). In contrast, the enhancing effects of haloperidol and (-)-sulpiride on striatal acetylcholine release remained unchanged up to day 12 of treatment. Thereafter, tolerance developed, so that both neuroleptics became totally ineffective on day 30 of treatment. Both on day 1 and 30, the neuroleptic-induced dopamine release was reversed by gamma-butyrolactone (gamma-hydroxybutyric acid lactone), suggesting that this effect is mediated by enhanced neuronal activity. On day 1 and day 10, the neuroleptic-induced acetylcholine release was antagonized by the blockade of dopamine D-1 receptors with SCH 39166 (trans-(-)-(6aS,13bR)-11-chloro-6,6a,7,8,9,13b-hexahydro-7-methyl-5H-benzo[d]napht[2,1-b]azepine-12-ol, hydrochloride) (0.5 mg/kg i.p.). SKF 38393 (1-phenyl-2,3,4,5-tetrahydro-(1H)-3-benzazepine-7,8-diol hydrochloride) (5 mg/kg i.p.) increased acetylcholine release by about 50% in control rats and in rats treated with (-)-sulpiride or haloperidol for up to 7 days. Its effect was blunted at day 14 and completely suppressed at day 30, suggesting that complete desensitization of dopamine D-1 receptors develops after chronic neuroleptic administration. The initial opposite action of neuroleptics on dopamine D-1 and D-2 receptors, and the development of desensitization of dopamine D-1 receptors, after chronic neuroleptic treatment, are discussed in terms of therapeutic and collateral effects of neuroleptics.
引用
收藏
页码:55 / 60
页数:6
相关论文
共 20 条
[1]   OBLIGATORY D-1 D-2 RECEPTOR INTERACTION IN THE GENERATION OF DOPAMINE AGONIST RELATED BEHAVIORS [J].
BRAUN, AR ;
CHASE, TN .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 131 (2-3) :301-306
[2]  
BUNNEY BS, 1973, J PHARMACOL EXP THER, V185, P560
[3]   ANTI-SCHIZOPHRENIC DRUGS - CHRONIC TREATMENT ELEVATES DOPAMINE RECEPTOR-BINDING IN BRAIN [J].
BURT, DR ;
CREESE, I ;
SNYDER, SH .
SCIENCE, 1977, 196 (4287) :327-328
[4]   DOPAMINE D1-RECEPTOR STIMULATION INCREASES STRIATAL ACETYLCHOLINE-RELEASE IN THE RAT [J].
DAMSMA, G ;
THAM, CS ;
ROBERTSON, GS ;
FIBIGER, HC .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 186 (2-3) :335-338
[5]  
DAMSMA G, 1991, J PHARMACOL EXP THER, V259, P1064
[6]  
Damsma G, 1991, MICRODIALYSIS NEUROS, P237
[7]   EFFECT OF CHRONIC TREATMENT WITH NNC 756, A NEW D-1 RECEPTOR ANTAGONIST, OR RACLOPRIDE, A D-2 RECEPTOR ANTAGONIST, IN DRUG-NAIVE CEBUS MONKEYS - DYSTONIA, DYSKINESIA AND D-1/D-2 SUPERSENSITIVITY [J].
GERLACH, J ;
HANSEN, L .
JOURNAL OF PSYCHOPHARMACOLOGY, 1993, 7 (04) :355-364
[8]  
IMPERATO A, 1984, J NEUROSCI, V4, P966
[9]   REPEATED STRESSFUL EXPERIENCES DIFFERENTLY AFFECT LIMBIC DOPAMINE RELEASE DURING AND FOLLOWING STRESS [J].
IMPERATO, A ;
ANGELUCCI, L ;
CASOLINI, P ;
ZOCCHI, A ;
PUGLISIALLEGRA, S .
BRAIN RESEARCH, 1992, 577 (02) :194-199
[10]   DOES DOPAMINE EXERT A TONIC INHIBITORY CONTROL ON THE RELEASE OF STRIATAL ACETYLCHOLINE IN-VIVO [J].
IMPERATO, A ;
OBINU, MC ;
DAZZI, L ;
GESSA, GL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 251 (2-3) :271-279